RecruitingNCT07242391

Menopausal Hormone Therapy And Left Ventricular Function

Menopausal Hormone Therapy And Neural Control Of Left Ventricular Function

Sponsor

Mayo Clinic

Enrollment

50 participants

Start Date

Aug 26, 2026

Study Type

OBSERVATIONAL

Conditions

Menopause Left Ventricular Dysfunction

Summary

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Menopausal Hormone Therapy for people with left ventricular dysfunction and menopause. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 45 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMenopausal Hormone Therapy

Taken in accordance with standard clinical practice, administered for a minimum duration of eight weeks.

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07242391

Related Trials

Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women

NCT07822230

A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects

NCT07794150